PL92078B1 - - Google Patents

Download PDF

Info

Publication number
PL92078B1
PL92078B1 PL1973182270A PL18227073A PL92078B1 PL 92078 B1 PL92078 B1 PL 92078B1 PL 1973182270 A PL1973182270 A PL 1973182270A PL 18227073 A PL18227073 A PL 18227073A PL 92078 B1 PL92078 B1 PL 92078B1
Authority
PL
Poland
Prior art keywords
formula
compounds
dihydrogen
radical
alkyl
Prior art date
Application number
PL1973182270A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL92078B1 publication Critical patent/PL92078B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
PL1973182270A 1972-03-06 1973-03-03 PL92078B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210687A DE2210687C3 (de) 1972-03-06 1972-03-06 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
PL92078B1 true PL92078B1 (no) 1977-03-31

Family

ID=5838037

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1973182270A PL92078B1 (no) 1972-03-06 1973-03-03
PL1973161010A PL89256B1 (no) 1972-03-06 1973-03-03

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1973161010A PL89256B1 (no) 1972-03-06 1973-03-03

Country Status (24)

Country Link
JP (2) JPS5626659B2 (no)
KR (1) KR780000119B1 (no)
AT (3) AT327904B (no)
BE (1) BE796279A (no)
BG (2) BG20583A3 (no)
CA (1) CA988524A (no)
CH (2) CH577473A5 (no)
CS (2) CS182781B2 (no)
DD (1) DD106833A5 (no)
DE (1) DE2210687C3 (no)
DK (1) DK136061C (no)
ES (1) ES412323A1 (no)
FI (1) FI55996C (no)
FR (1) FR2181789B1 (no)
GB (1) GB1379005A (no)
HU (1) HU167089B (no)
IE (1) IE37370B1 (no)
IL (1) IL41664A (no)
LU (1) LU67147A1 (no)
NL (1) NL7303137A (no)
PL (2) PL92078B1 (no)
RO (2) RO61192A (no)
SE (1) SE384208B (no)
ZA (1) ZA731501B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen
JPS5922593U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 ヘツドホ−ン用ホ−ン部取付構造
JPS5922594U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 耳栓型ヘツドホ−ン
JPS6282898A (ja) * 1985-10-08 1987-04-16 Matsushita Electric Ind Co Ltd ヘツドホン
JPS6293060U (no) * 1985-11-28 1987-06-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3855231A (en) * 1972-03-06 1974-12-17 Bayer Ag 2,6-diamino-1,4-dihydropyridine derivatives
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen

Also Published As

Publication number Publication date
BG22815A3 (no) 1977-04-20
BE796279A (fr) 1973-09-05
ATA925774A (de) 1975-05-15
DK136061B (da) 1977-08-08
ZA731501B (en) 1973-11-28
CH577473A5 (no) 1976-07-15
AT324338B (de) 1975-08-25
IL41664A (en) 1976-01-30
DK136061C (da) 1978-01-02
AT327904B (de) 1976-02-25
IE37370L (en) 1973-09-06
CH580589A5 (no) 1976-10-15
PL89256B1 (no) 1976-11-30
FR2181789B1 (no) 1976-12-03
DE2210687A1 (de) 1973-09-20
CS182792B2 (en) 1978-05-31
NL7303137A (no) 1973-09-10
CA988524A (en) 1976-05-04
IL41664A0 (en) 1973-05-31
DE2210687B2 (de) 1980-09-04
FI55996B (fi) 1979-07-31
IE37370B1 (en) 1977-07-06
KR780000119B1 (en) 1978-04-15
BG20583A3 (no) 1975-12-05
RO61192A (no) 1976-09-15
JPS5911584B2 (ja) 1984-03-16
DE2210687C3 (de) 1981-09-24
DD106833A5 (no) 1974-07-05
GB1379005A (en) 1975-01-02
JPS48103579A (no) 1973-12-25
ES412323A1 (es) 1976-01-01
FI55996C (fi) 1979-11-12
LU67147A1 (no) 1973-05-22
CS182781B2 (en) 1978-05-31
RO63068A (no) 1978-05-15
HU167089B (no) 1975-08-28
JPS5626659B2 (no) 1981-06-19
FR2181789A1 (no) 1973-12-07
SE384208B (sv) 1976-04-26
JPS5699460A (en) 1981-08-10

Similar Documents

Publication Publication Date Title
US3708489A (en) Azido-aryl 1,4-dihydropyridines and their production
PL147842B1 (en) Method of obtaining novel pyroisobenzimidazoles
PL89257B1 (no)
PL92407B1 (no)
JPS5973572A (ja) 新規なジヒドロピリミジン類
AU570529B2 (en) 5-heteroarylimidazol-2-ones
US3777030A (en) Sulphur-containing 1,4-dihydropyri-dine derivatives for coronary ves-sel dilation
SK279326B6 (sk) Antihypertenzívne zlúčeniny a farmaceutický prostr
PL89258B1 (no)
SU828967A3 (ru) Способ получени гуанидиновых производныхили иХ КиСлОТНО-АддиТиВНыХ СОлЕй,или иХ КОМплЕКСОВ C НЕОРгАНичЕСКиМиСОл Ми МЕТАллОВ
US4539321A (en) 5-Diaza-aryl-3-substituted pyridone compounds
US4835154A (en) 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors
JPS61291567A (ja) 新規な1,4−ジヒドロピリジン類
PL92078B1 (no)
US4617393A (en) 5-substituted-6-aminopyrimidines, composition and uses as cardiotonic agents for increasing cardiac contractility
JPS6261960A (ja) 不可逆性ド−パミン−β−ヒドロキシラ−ゼ抑制剤
US4661484A (en) Pyridazinone derivatives and salts thereof as cardiac stimulants
PL89414B1 (no)
JPS6322049A (ja) 不可逆的ド−パミン−β−ヒドロキシラ−ゼ抑制剤
EP0145019B1 (en) Pyridazinone derivatives and salts thereof
PT78491B (en) Process for the preparation of new 5-acyl-2-(1h)-pyridinones useful as cardiotonic agents
US4147805A (en) Alkylthiophenoxyalkylamines and the pharmaceutical use thereof
NO145574B (no) Analogifremgangsmaate til fremstilling av 2,6-dimetyl-3-metoksykarbonyl-4-(2`-nitrofenyl)-1,4-dihydropyridin-5-karboksylsyreisobutylester
US3629443A (en) Therapeutic composition containing a mandelamidine derivative
JPH0723349B2 (ja) 3,5−ジ−タ−シヤリ−ブチル−4−ヒドロキシケイ皮酸アミド誘導体